Consun Pharma Adds 0.07 Million Treasury Shares After HK$0.93 Million Buyback

Bulletin Express06-10 20:43

On 10 June 2026, Consun Pharmaceutical Group Limited executed an on-market repurchase of 67,000 ordinary shares, spending HK$0.93 million at prices ranging from HK$13.71 to HK$13.97 per share. The volume-weighted average price stood at HK$13.85.

\n\nFollowing the transaction, issued shares outstanding (excluding treasury stock) fell from 840.39 million to 840.32 million, a marginal 0.008% reduction. Treasury shares increased to 1.23 million, while the company’s total issued share count remained unchanged at 841.55 million.

\n\nThe buyback forms part of the mandate approved on 26 May 2026, which authorises repurchases of up to 84.12 million shares. To date, Consun Pharma has repurchased 0.89 million shares under this mandate, utilising around 1.05% of the authorised limit. In line with Hong Kong Stock Exchange requirements, the company is subject to a moratorium on new share issues or treasury-share sales until 10 July 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1144561267?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-10 20:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1144561267","market":"us","top_or_hot":-1,"title":"Consun Pharma Adds 0.07 Million Treasury Shares After HK$0.93 Million Buyback","media":"Bulletin Express","content":"<p>On 10 June 2026, Consun Pharmaceutical Group Limited executed an on-market repurchase of 67,000 ordinary shares, spending HK$0.93 million at prices ranging from HK$13.71 to HK$13.97 per share. The volume-weighted average price stood at HK$13.85.</p>\n<p>\\n\\nFollowing the transaction, issued shares outstanding (excluding treasury stock) fell from 840.39 million to 840.32 million, a marginal 0.008% reduction. Treasury shares increased to 1.23 million, while the company’s total issued share count remained unchanged at 841.55 million.</p>\n<p>\\n\\nThe buyback forms part of the mandate approved on 26 May 2026, which authorises repurchases of up to 84.12 million shares. To date, Consun Pharma has repurchased 0.89 million shares under this mandate, utilising around 1.05% of the authorised limit. In line with Hong Kong Stock Exchange requirements, the company is subject to a moratorium on new share issues or treasury-share sales until 10 July 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Consun Pharma Adds 0.07 Million Treasury Shares After HK$0.93 Million Buyback</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nConsun Pharma Adds 0.07 Million Treasury Shares After HK$0.93 Million Buyback\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-10 20:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>On 10 June 2026, Consun Pharmaceutical Group Limited executed an on-market repurchase of 67,000 ordinary shares, spending HK$0.93 million at prices ranging from HK$13.71 to HK$13.97 per share. The volume-weighted average price stood at HK$13.85.</p>\n<p>\\n\\nFollowing the transaction, issued shares outstanding (excluding treasury stock) fell from 840.39 million to 840.32 million, a marginal 0.008% reduction. Treasury shares increased to 1.23 million, while the company’s total issued share count remained unchanged at 841.55 million.</p>\n<p>\\n\\nThe buyback forms part of the mandate approved on 26 May 2026, which authorises repurchases of up to 84.12 million shares. To date, Consun Pharma has repurchased 0.89 million shares under this mandate, utilising around 1.05% of the authorised limit. In line with Hong Kong Stock Exchange requirements, the company is subject to a moratorium on new share issues or treasury-share sales until 10 July 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01681","symbol_name":"康臣药业","start_time":0,"source_url":"","article_id":"1144561267","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1144561267","pubTimestamp":1781095385,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"On 10 June 2026, Consun Pharmaceutical Group Limited executed an on-market repurchase of 67,000 ordinary shares, spending HK$0.93 million at prices ranging from HK$13.71 to HK$13.97 per share. The...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01681":"康臣药业"},"translate_title":"康臣药业回购93万港元后增持7万股库存股","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01681":1},"content_text":"On 10 June 2026, Consun Pharmaceutical Group Limited executed an on-market repurchase of 67,000 ordinary shares, spending HK$0.93 million at prices ranging from HK$13.71 to HK$13.97 per share. The volume-weighted average price stood at HK$13.85.\n\\n\\nFollowing the transaction, issued shares outstanding (excluding treasury stock) fell from 840.39 million to 840.32 million, a marginal 0.008% reduction. Treasury shares increased to 1.23 million, while the company’s total issued share count remained unchanged at 841.55 million.\n\\n\\nThe buyback forms part of the mandate approved on 26 May 2026, which authorises repurchases of up to 84.12 million shares. To date, Consun Pharma has repurchased 0.89 million shares under this mandate, utilising around 1.05% of the authorised limit. In line with Hong Kong Stock Exchange requirements, the company is subject to a moratorium on new share issues or treasury-share sales until 10 July 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1144561267","isCrawlerRequest":true}